Evidence map›Paper›PMID 32793122›Full record

ArticleFrontiers in endocrinology2020

Proton Pump Inhibitors and Osteoporosis: Is Collagen a Direct Target?

Yohannes T Ghebre

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Drug-Induced Osteoporosis.Journal of clinical medicine · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yohannes T GhebreDepartment of Radiation Oncology, Baylor College of Medicine, Houston, TX, United States.

Funding

Combination of PPI and pirfenidone to enhance antifibrotic efficacyR01HL137703 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHEBRE, YOHANNES T · 2017 to 2021
$2.0M
DDAH As a Novel Target in Pulmonary FibrosisK01HL118683 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI GHEBRE, YOHANNES T · 2013 to 2017
$682k
Repurposing esomeprazole for the treatment of sclerodermaR56AR077445 · NIAMS · BAYLOR COLLEGE OF MEDICINE · PI GHEBRE, YOHANNES T · 2020 to 2020
$352k
NHLBI NIH HHS K01 HL118683NHLBI NIH HHS R01 HL137703NIAMS NIH HHS R56 AR077445
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CollagenHumansOsteoporosisProton Pump InhibitorsCollagenProton Pump Inhibitorsbone densitycollagenosteoporosisosteoporotic fracturesproton pump inhibitors

Identifiers

PMID32793122
PMCPMC7387407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.